KCT0002460进行中（未招募）未知
Studies on evaluation ofimmunogenicity of meningococcal vaccine in Korea
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 50(Year)（—）
- 性别
- All
入选标准
- •Eligible individuals were healthy adults aged 19-50 years old who gave informed consents.
排除标准
- •Subjects were excluded if they had a history of a previous meningococcal disease or Guillan-Barre Syndrome, immunization with meningococcal vaccines, a disease requiring treatment using immunosuppressive drugs, a history of hypersensitivity to vaccines or any vaccine components, or receipt of antibiotics within seven days. Subjects were also excluded if they received a blood products (including immunoglobulin) within 6 months.
研究者
相似试验
已完成
3 期
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of AgeInfections, MeningococcalNCT01767376GlaxoSmithKline692
招募中
1 期
Meningococcal B vaccine in patients with aspleniaSplenectomyMedDRA version: 20.0Level: PTClassification code: 10041642Term: Splenectomy Class: 100000004865CTIS2023-508192-36-00Medical University of Vienna80
招募中
4 期
MENPI: Safety and immunogenicity following meningococcal and pneumococcal immunization among adult people living with HIV. A single center, non-blinded, randomized clinical trial2024-516961-35-01Hvidovre Hospital55
进行中（未招募）
4 期
Meningococcal vaccine for 56 years old or olderJPRN-jRCT1061190014Tanaka Takaaki20
已完成
不适用
Immunogenicity and safety of quadrivalent meningococcal polysaccharide-protein conjugate vaccine among Japanese people aged >=56 yearsmeningococcal diseaseJPRN-UMIN000022803Tokyo Medical University Hospital Travellers' Medical Center23